Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

59.5%
Female
40.5%
Male

Age Information

The average age of patients reporting adverse events with PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE is 62.7 years.

Geographic Distribution

The majority of adverse event reports for PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE originate from US.

Report Summary & Outcomes

16,356
Total Reports
16,356
As Primary/Secondary Suspect
2,245
Deaths Reported
4,214
Hospitalizations
103
Life-Threatening
89
Disabilities

Reporting Timeline

First adverse event report: 1947. Most recent report: 20250919. View full timeline →

More About PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE

PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE Full Profile Reports by Year Drug Interactions